Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid to reduce blood loss in elective caesarean section
PACTR202011872201172Phase 4Completed
- Sponsor
- JEMIRIGBE OMAWUMI DARLINGTON
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Intravenous tranexamic acid with Placebo (2 arms). Primary endpoint: Amount of blood loss during and after caesarean section. Started Jun 2020; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on PACTR202011872201172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202011872201172.